Pancreatic Cancer Research

ResearcherQueen Mary University of LondonNo recent work listed

Constantia Pantelidou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2750-9352; OpenAlex author ID A5034379066. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper

Papers 2

  1. The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells. Co-author DOI 10.1158/1535-7163.mct-17-0671↗
  2. The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11. Co-author DOI 10.18632/oncotarget.7310↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gunnel Halldén · 2 shared papers, 2016–2018 · strength 0.17
  2. Y. K. Stella Man · 1 shared paper, 2018 · strength 0.09
  3. Alan L. Parker · 1 shared paper, 2018 · strength 0.09
  4. John F. Marshall · 1 shared paper, 2018 · strength 0.09
  5. Gioia Cherubini · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.